NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker. Yang W, Wu X, Cai F, Guo Z, et al. Cancer Sci 2025;116:2400-2412.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang W, Wu X, Cai F, Guo Z, et al. NFATc4 Promotes Lung Adenocarcinoma Progression via the CCNB1/CDK1 Pathway and Is a Potential Prognostic Biomarker. Cancer Sci 2025;116:2400-2412.
PMID: 40639671